Changes of gut microbiota during silybin‐mediated treatment of high‐fat diet‐induced non‐alcoholic fatty liver disease in mice
Author:
Affiliation:
1. Eastern Hospital, Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu China
2. Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital Chengdu China
Funder
Innovative Research Group Project of the National Natural Science Foundation of China
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13444
Reference26 articles.
1. Non-alcoholic fatty liver disease
2. The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
3. Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development
4. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease;Suk KT;Expert Review of Gastroenterology and Hepatology,2019
5. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial;Lipids in Health and Disease;2024-08-03
2. Silibinin Targeting Heat Shock Protein 90 Represents a Novel Approach to Alleviate Nonalcoholic Fatty Liver Disease by Simultaneously Lowering Hepatic Lipotoxicity and Enhancing Gut Barrier Function;ACS Pharmacology & Translational Science;2024-07-01
3. The effect of rifaximin and lactulose treatments to chronic hepatic encephalopathy rats: An [18F]PBR146 in‐vivo neuroinflammation imaging study;Brain and Behavior;2024-07
4. Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice;Nutrients;2024-04-14
5. Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota;Frontiers in Cellular and Infection Microbiology;2024-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3